Swedbank AB lifted its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,915,250 shares of the company’s stock after acquiring an additional 103,134 shares during the quarter. Swedbank AB owned about 0.42% of Zoetis worth $312,052,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. Darwin Wealth Management LLC acquired a new stake in Zoetis in the 3rd quarter valued at approximately $31,000. First Personal Financial Services bought a new position in Zoetis in the 3rd quarter valued at approximately $33,000. Capital Performance Advisors LLP bought a new stake in shares of Zoetis in the third quarter worth $33,000. Dunhill Financial LLC increased its holdings in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after purchasing an additional 75 shares in the last quarter. Finally, Quarry LP increased its stake in Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.
Wall Street Analysts Forecast Growth
ZTS has been the topic of a number of research analyst reports. UBS Group began coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price on the stock. Stifel Nicolaus decreased their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Leerink Partners began coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. Finally, JPMorgan Chase & Co. increased their target price on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Zoetis presently has an average rating of “Buy” and an average target price of $211.89.
Zoetis Price Performance
Shares of Zoetis stock traded up $0.11 during trading on Wednesday, hitting $170.53. 153,840 shares of the stock traded hands, compared to its average volume of 2,627,880. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The stock has a market cap of $76.94 billion, a price-to-earnings ratio of 32.01, a PEG ratio of 2.57 and a beta of 0.89. The firm’s fifty day moving average is $169.93 and its 200-day moving average is $179.65.
Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same period last year, the firm earned $1.36 earnings per share. The business’s quarterly revenue was up 11.6% on a year-over-year basis. Research analysts expect that Zoetis Inc. will post 5.9 EPS for the current fiscal year.
Zoetis Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.17%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. Zoetis’s dividend payout ratio (DPR) is 37.59%.
Zoetis Company Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
- Five stocks we like better than Zoetis
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Steel Stocks Soaring After Tariff Announcements
- What Makes a Stock a Good Dividend Stock?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- What Investors Need to Know to Beat the Market
- Why Salesforce Stock Could Be at Fresh Highs by February
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.